Indocyanine green angiography of multifocal choroiditis.
OBJECTIVE
The purpose of the study is to determine indocyanine green (ICG) angiographic characteristics of patients with multifocal choroiditis (MC) and to identify features that may assist in the differentiation of MC from other ocular inflammatory diseases.


METHODS
After complete ophthalmologic examination, fluorescein angiography and ICG angiography were performed in a series of 14 patients with MC. The ICG findings were then correlated with the clinical and fluorescein angiographic appearance of these patients to determine specific characteristics and distinguishing features of the entity. These findings then were compared with those of angiographic patterns observed in patients with ocular histoplasmosis syndrome to determine whether differentiating features could be identified.


RESULTS
Fourteen (50%) of the 28 eyes were found to have large hypofluorescent spots in the posterior pole on ICG angiography, which, in most cases, did not correspond to clinically or fluorescein angiographically detectable lesions. Seventeen (61%) had smaller hypofluorescent lesions (approximately 50 pm in size) in the posterior pole on the ICG study. In seven eyes exhibiting enlarged blind spots on visual field testing, ICG angiography showed confluent hypofluorescence surrounding the optic nerve. The ICG angiogram was found useful in evaluating the natural course in two patients with MC as well as a response to oral prednisone therapy in four others. The ICG angiographic findings differed from those seen in patients with ocular histoplasmosis.


CONCLUSIONS
Indocyanine green angiography can provide information that is not detectable by clinical or fluorescein angiographic examination in patients with MC. This information may prove useful in differentiating this condition from the ocular histoplasmosis syndrome, provide a better understanding of the natural course and progression of the disease, and provide a potential adjunct in the clinical evaluation of patients undergoing therapeutic regimens for active inflammatory lesions.
Slakter
J S
JS
LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear and Throat Hospital, New York, New York, USA.
Giovannini
A
A
Yannuzzi
L A
LA
Scassellati-Sforzolini
B
B
Guyer
D R
DR
Sorenson
J A
JA
Spaide
R F
RF
Orlock
D
D
D000293:Adolescent; D000328:Adult; D002829:Choroid / Q000473:pathology*; D002833:Choroiditis / Q000175:diagnosis*; D004396:Coloring Agents; D003937:Diagnosis, Differential; D015821:Eye Infections, Fungal / Q000175:diagnosis; D005260:Female; D005451:Fluorescein Angiography; D006660:Histoplasmosis / Q000175:diagnosis; D006801:Humans; D007208:Indocyanine Green; D008297:Male; D008875:Middle Aged; D013577:Syndrome
D004396:Coloring Agents; D007208:Indocyanine Green